{"entity":{"type":"insider","cik":"0001932445","url":"/insider/0001932445","json_url":"/insider/0001932445.json","name":"TCG Opportunity III GP, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":62,"n_filings":28,"first":"2022-10-27","last":"2026-02-26","span_basis":"filed_date"},"name_variants":[{"name":"TCG Opportunity III GP, LLC","source":"filing","n_filings":28,"first_seen":"2022-10-27","last_seen":"2026-02-26"}],"transactions":[{"id":6036469,"accession":"0001193125-26-076814","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-076814","line_url":"/filing/0001193125-26-076814","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3511826.0,"shares_display":"3,511,826","price_per_share":0.5624,"price_display":"0.56","price_state":"stated","total_value":1975050.9424,"total_display":"1,975,050.94","total_whole":"1,975,051","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider","n_lines":2},{"id":6036463,"accession":"0001193125-26-076814","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-076814","line_url":"/filing/0001193125-26-076814","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":658440.0,"shares_display":"658,440","price_per_share":0.6153,"price_display":"0.62","price_state":"stated","total_value":405138.132,"total_display":"405,138.13","total_whole":"405,138","shares_owned_after":1862545.0,"shares_owned_after_display":"1,862,545","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-26","scope":"insider","n_lines":2},{"id":6171220,"accession":"0001193125-26-067007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-067007","line_url":"/filing/0001193125-26-067007","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":306000.0,"shares_display":"306,000","price_per_share":0.5972,"price_display":"0.60","price_state":"stated","total_value":182743.2,"total_display":"182,743.20","total_whole":"182,743","shares_owned_after":2211757.0,"shares_owned_after_display":"2,211,757","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-24","scope":"insider","n_lines":2},{"id":6171211,"accession":"0001193125-26-067007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-067007","line_url":"/filing/0001193125-26-067007","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":523734.0,"shares_display":"523,734","price_per_share":0.6149,"price_display":"0.61","price_state":"stated","total_value":322044.0366,"total_display":"322,044.04","total_whole":"322,044","shares_owned_after":2374048.0,"shares_owned_after_display":"2,374,048","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-20","filed_date":"2026-02-24","scope":"insider","n_lines":2},{"id":5762216,"accession":"0001193125-26-049028","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-049028","line_url":"/filing/0001193125-26-049028","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4056573.0,"shares_display":"4,056,573","price_per_share":0.6808,"price_display":"0.68","price_state":"stated","total_value":2761714.8984,"total_display":"2,761,714.90","total_whole":"2,761,715","shares_owned_after":2651817.0,"shares_owned_after_display":"2,651,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-12","scope":"insider","n_lines":2},{"id":5762214,"accession":"0001193125-26-049028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-049028","line_url":"/filing/0001193125-26-049028","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":343717.0,"shares_display":"343,717","price_per_share":0.8161,"price_display":"0.82","price_state":"stated","total_value":280507.4437,"total_display":"280,507.44","total_whole":"280,507","shares_owned_after":4803275.0,"shares_owned_after_display":"4,803,275","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-12","scope":"insider","n_lines":2},{"id":5958428,"accession":"0001193125-26-043320","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001193125-26-043320","line_url":"/filing/0001193125-26-043320","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Eikon Therapeutics, Inc.","issuer_ticker":"EIKN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"Column Group IV GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2117760.0,"shares_display":"2,117,760","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":38119680.0,"total_display":"38,119,680.00","total_whole":"38,119,680","shares_owned_after":4312139.0,"shares_owned_after_display":"4,312,139","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider","n_lines":3},{"id":6194331,"accession":"0001193125-26-016991","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-26-016991","line_url":"/filing/0001193125-26-016991","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18052.0,"shares_display":"18,052","price_per_share":19.5999,"price_display":"19.60","price_state":"stated","total_value":353817.3948,"total_display":"353,817.39","total_whole":"353,817","shares_owned_after":1016658.0,"shares_owned_after_display":"1,016,658","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-20","scope":"insider","n_lines":2},{"id":6194311,"accession":"0001193125-26-016991","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-016991","line_url":"/filing/0001193125-26-016991","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2562.0,"shares_display":"2,562","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":51240.0,"total_display":"51,240.00","total_whole":"51,240","shares_owned_after":1007090.0,"shares_owned_after_display":"1,007,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider","n_lines":2},{"id":6194306,"accession":"0001193125-26-016991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-016991","line_url":"/filing/0001193125-26-016991","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11893.0,"shares_display":"11,893","price_per_share":19.889,"price_display":"19.89","price_state":"stated","total_value":236539.877,"total_display":"236,539.88","total_whole":"236,540","shares_owned_after":1005732.0,"shares_owned_after_display":"1,005,732","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-20","scope":"insider","n_lines":2},{"id":6015971,"accession":"0001193125-26-014100","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-014100","line_url":"/filing/0001193125-26-014100","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5523.0,"shares_display":"5,523","price_per_share":19.9883,"price_display":"19.99","price_state":"stated","total_value":110395.3809,"total_display":"110,395.38","total_whole":"110,395","shares_owned_after":999429.0,"shares_owned_after_display":"999,429","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-14","filed_date":"2026-01-15","scope":"insider","n_lines":2},{"id":6015964,"accession":"0001193125-26-014100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-014100","line_url":"/filing/0001193125-26-014100","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12470.0,"shares_display":"12,470","price_per_share":19.8041,"price_display":"19.80","price_state":"stated","total_value":246957.127,"total_display":"246,957.13","total_whole":"246,957","shares_owned_after":996502.0,"shares_owned_after_display":"996,502","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider","n_lines":2},{"id":6194235,"accession":"0001193125-26-007857","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-007857","line_url":"/filing/0001193125-26-007857","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15100.0,"shares_display":"15,100","price_per_share":19.8872,"price_display":"19.89","price_state":"stated","total_value":300296.72,"total_display":"300,296.72","total_whole":"300,297","shares_owned_after":989893.0,"shares_owned_after_display":"989,893","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider","n_lines":2},{"id":4093590,"accession":"0001193125-25-311384","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-311384","line_url":"/filing/0001193125-25-311384","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30884.0,"shares_display":"30,884","price_per_share":19.5409,"price_display":"19.54","price_state":"stated","total_value":603501.1556,"total_display":"603,501.16","total_whole":"603,501","shares_owned_after":981890.0,"shares_owned_after_display":"981,890","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-08","scope":"insider","n_lines":2},{"id":4093581,"accession":"0001193125-25-311384","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-311384","line_url":"/filing/0001193125-25-311384","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5266.0,"shares_display":"5,266","price_per_share":17.347,"price_display":"17.35","price_state":"stated","total_value":91349.302,"total_display":"91,349.30","total_whole":"91,349","shares_owned_after":965509.0,"shares_owned_after_display":"965,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-08","scope":"insider","n_lines":2},{"id":4796054,"accession":"0001193125-25-284943","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-284943","line_url":"/filing/0001193125-25-284943","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":315457.0,"shares_display":"315,457","price_per_share":12.65,"price_display":"12.65","price_state":"stated","total_value":3990531.05,"total_display":"3,990,531.05","total_whole":"3,990,531","shares_owned_after":962718.0,"shares_owned_after_display":"962,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-17","scope":"insider","n_lines":2},{"id":4235371,"accession":"0000950170-25-047104","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-047104","line_url":"/filing/0000950170-25-047104","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1034482.0,"shares_display":"1,034,482","price_per_share":11.6,"price_display":"11.60","price_state":"stated","total_value":11999991.2,"total_display":"11,999,991.20","total_whole":"11,999,991","shares_owned_after":795411.0,"shares_owned_after_display":"795,411","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-03-28","scope":"insider","n_lines":3},{"id":4099898,"accession":"0000950170-25-035789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-035789","line_url":"/filing/0000950170-25-035789#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35714284.0,"shares_display":"35,714,284","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":24999998.8,"total_display":"24,999,998.80","total_whole":"24,999,999","shares_owned_after":49313559.0,"shares_owned_after_display":"49,313,559","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":2234984,"accession":"0000950170-24-015234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-015234","line_url":"/filing/0000950170-24-015234#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2222222.0,"shares_display":"2,222,222","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":9999999.0,"total_display":"9,999,999.00","total_whole":"9,999,999","shares_owned_after":13599275.0,"shares_owned_after_display":"13,599,275","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-14","scope":"insider"},{"id":8530688,"accession":"0000950170-23-064858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-064858","line_url":"/filing/0000950170-23-064858#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP L P; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP L P","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5840.0,"shares_display":"5,840","price_per_share":0.6211,"price_display":"0.62","price_state":"stated","total_value":3627.224,"total_display":"3,627.22","total_whole":"3,627","shares_owned_after":949862.0,"shares_owned_after_display":"949,862","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":8530685,"accession":"0000950170-23-064858","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-064858","line_url":"/filing/0000950170-23-064858#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP L P; TCG Opportunity III GP, LLC","owner_display_name":"COLUMN GROUP L P","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16791.0,"shares_display":"16,791","price_per_share":0.7075,"price_display":"0.71","price_state":"stated","total_value":11879.6325,"total_display":"11,879.63","total_whole":"11,880","shares_owned_after":944022.0,"shares_owned_after_display":"944,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8032682,"accession":"0000899243-23-008390","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-008390","line_url":"/filing/0000899243-23-008390#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"Column Group Opportunity III GP, LP; COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; TCG Opportunity III GP, LLC; COLUMN GROUP III-A, LP; Column Group Opportunity III, LP","owner_display_name":"Column Group Opportunity III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6779.0,"shares_display":"6,779","price_per_share":2.5956,"price_display":"2.60","price_state":"stated","total_value":17595.5724,"total_display":"17,595.57","total_whole":"17,596","shares_owned_after":11377053.0,"shares_owned_after_display":"11,377,053","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-14","scope":"insider"},{"id":8669129,"accession":"0000899243-23-004584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-004584","line_url":"/filing/0000899243-23-004584#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; Column Group Opportunity III GP, LP; TCG Opportunity III GP, LLC; COLUMN GROUP III-A, LP; Column Group Opportunity III, LP","owner_display_name":"COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":3900000.0,"total_display":"3,900,000.00","total_whole":"3,900,000","shares_owned_after":11370274.0,"shares_owned_after_display":"11,370,274","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-10","scope":"insider"},{"id":7833963,"accession":"0000899243-23-003132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-003132","line_url":"/filing/0000899243-23-003132#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG Opportunity III GP, LLC; COLUMN GROUP L P","owner_display_name":"TCG Opportunity III GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":176730.0,"shares_display":"176,730","price_per_share":4.9986,"price_display":"5.00","price_state":"stated","total_value":883402.578,"total_display":"883,402.58","total_whole":"883,403","shares_owned_after":927231.0,"shares_owned_after_display":"927,231","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-01","scope":"insider"},{"id":7833960,"accession":"0000899243-23-003132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-003132","line_url":"/filing/0000899243-23-003132#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG Opportunity III GP, LLC; COLUMN GROUP L P","owner_display_name":"TCG Opportunity III GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7542.0,"shares_display":"7,542","price_per_share":4.9996,"price_display":"5.00","price_state":"stated","total_value":37706.9832,"total_display":"37,706.98","total_whole":"37,707","shares_owned_after":750501.0,"shares_owned_after_display":"750,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider"},{"id":8694188,"accession":"0000899243-23-002642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002642","line_url":"/filing/0000899243-23-002642#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG Opportunity III GP, LLC; COLUMN GROUP L P","owner_display_name":"TCG Opportunity III GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9900.0,"shares_display":"9,900","price_per_share":4.9994,"price_display":"5.00","price_state":"stated","total_value":49494.06,"total_display":"49,494.06","total_whole":"49,494","shares_owned_after":742959.0,"shares_owned_after_display":"742,959","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":8740598,"accession":"0000899243-23-002381","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002381","line_url":"/filing/0000899243-23-002381#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG Opportunity III GP, LLC; COLUMN GROUP L P","owner_display_name":"TCG Opportunity III GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.996,"price_display":"5.00","price_state":"stated","total_value":2498.0,"total_display":"2,498.00","total_whole":"2,498","shares_owned_after":733059.0,"shares_owned_after_display":"733,059","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-23","scope":"insider"},{"id":8740595,"accession":"0000899243-23-002381","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002381","line_url":"/filing/0000899243-23-002381#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG Opportunity III GP, LLC; COLUMN GROUP L P","owner_display_name":"TCG Opportunity III GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37639.0,"shares_display":"37,639","price_per_share":4.9976,"price_display":"5.00","price_state":"stated","total_value":188104.6664,"total_display":"188,104.67","total_whole":"188,105","shares_owned_after":732559.0,"shares_owned_after_display":"732,559","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-23","scope":"insider"},{"id":8720429,"accession":"0000899243-23-002382","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002382","line_url":"/filing/0000899243-23-002382#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; TCG Opportunity III GP, LLC; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; COLUMN GROUP III-A, LP; COLUMN GROUP III GP, LP","owner_display_name":"COLUMN GROUP III, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69739.0,"shares_display":"69,739","price_per_share":2.4979,"price_display":"2.50","price_state":"stated","total_value":174201.0481,"total_display":"174,201.05","total_whole":"174,201","shares_owned_after":9870274.0,"shares_owned_after_display":"9,870,274","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-23","scope":"insider"},{"id":8421246,"accession":"0000899243-23-002161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002161","line_url":"/filing/0000899243-23-002161#line-2","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"Column Group Opportunity III, LP; Column Group Opportunity III GP, LP; TCG Opportunity III GP, LLC; COLUMN GROUP III, LP; COLUMN GROUP III GP, LP; COLUMN GROUP III-A, LP","owner_display_name":"Column Group Opportunity III, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":135688.0,"shares_display":"135,688","price_per_share":2.5163,"price_display":"2.52","price_state":"stated","total_value":341431.7144,"total_display":"341,431.71","total_whole":"341,432","shares_owned_after":9800535.0,"shares_owned_after_display":"9,800,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"},{"id":8421240,"accession":"0000899243-23-002161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002161","line_url":"/filing/0000899243-23-002161#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"Column Group Opportunity III, LP; Column Group Opportunity III GP, LP; TCG Opportunity III GP, LLC; COLUMN GROUP III, LP; COLUMN GROUP III GP, LP; COLUMN GROUP III-A, LP","owner_display_name":"Column Group Opportunity III, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49463.0,"shares_display":"49,463","price_per_share":2.4947,"price_display":"2.49","price_state":"stated","total_value":123395.3461,"total_display":"123,395.35","total_whole":"123,395","shares_owned_after":9664847.0,"shares_owned_after_display":"9,664,847","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"}],"collapsed":true,"next_cursor":"2023-01-17|8421240","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001858848","name":"Tenaya Therapeutics, Inc.","url":"/issuer/0001858848","role":"Ten percent owner","n_filings":10,"first_seen":"2022-11-23","last_seen":"2026-02-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001861123","name":"Eikon Therapeutics, Inc.","url":"/issuer/0001861123","role":"Ten percent owner","n_filings":1,"first_seen":"2026-02-09","last_seen":"2026-02-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001824893","name":"Surrozen, Inc./DE","url":"/issuer/0001824893","role":"Ten percent owner","n_filings":6,"first_seen":"2025-03-28","last_seen":"2026-01-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001426332","name":"NGM BIOPHARMACEUTICALS INC","url":"/issuer/0001426332","role":"Ten percent owner","n_filings":11,"first_seen":"2022-10-27","last_seen":"2023-11-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001932445","retrieved_at":"2026-08-22T20:48:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}